Skip to content
PayClear Ledger
Directory

1v1 Institutional Counterparty Comparison

Barclays vs Conotoxia: Regulation, 6D Ratings & Safety Audit

Deterministic head-to-head benchmarking of Barclays (Barclays) and Conotoxia (Conotoxia Ltd) across primary regulatory filings, statutory Tier-1 authorisations, 6-Dimension compliance scores, execution software, and warning exposure.

Coverage: Cross-border payment institutions, MSBs, remittance corridors, insurance and fiduciary trusts

Barclays 6D Score
5.0
Conotoxia 6D Score
6.1
Regulated Licences
2 vs 3
Warning Flags
0 vs 0
DETERMINISTIC QUANTITATIVE VERDICTCanonical Pair: barclays-vs-conotoxia

Conotoxia outranks Barclays by +1.1 pts in composite 6D scoring (6.1 vs 5.0)

On supervisory breadth, Barclays holds 2 active regulated licence(s) (0 Tier-1) out of 2 total filings and 0 warning count(s), whereas Conotoxia holds 3 active regulated licence(s) (0 Tier-1) out of 3 total filings and 0 warning count(s). Allocators should inspect the individual licence numbers and contracting legal entities below before onboarding.

6-Dimension Quantitative Scorecard Comparison

Head-to-head breakdown across all 6 proprietary evaluation dimensions (0.0–10.0 scale).

Evaluation DimensionMethodology WeightBarclaysConotoxiaScore DeltaDimension Leader
Overall Composite 6D Score100% Composite5.06.1+1.1Conotoxia
Regulatory & Licensing Integrity (riskScore)30% Weight5.05.00.0Statistical Tie
Execution & Software Infrastructure (industryScore)20% Weight3.04.0+1.0Conotoxia
User Reputation & Complaint Telemetry (userScore)20% Weight0.00.00.0Statistical Tie
Institutional Brand Longevity (brandScore)15% Weight5.06.3+1.3Conotoxia
Global Market Influence & Footprint (influenceScore)15% Weight5.05.00.0Statistical Tie

Visual Architecture Benchmark: Barclays vs Conotoxia

Vector comparison exhibit generated from live supervisory snapshot metrics.

1v1 Institutional Counterparty Benchmark: Barclays vs Conotoxia
Exhibit: Side-by-side regulatory and 6D quantitative comparison between Barclays and Conotoxia.

Regulatory Standing, Entity & Platform Comparison

Structural comparison of supervisory authorisations, domicile, execution terminals, and risk telemetry.

Audit AttributeBarclaysConotoxia
Primary Legal NameBarclaysConotoxia Ltd
Source Risk ClassificationRisk level not suppliedRisk level not supplied
Active Regulated / Total Filings2 regulated / 2 total (0 Tier-1)3 regulated / 3 total (0 Tier-1)
Recorded Certificate Numbers
CYSEC: #336/17KNF: Not suppliedCONSOB: Not supplied
Registered Domicile / AddressUnited Kingdom London Canary Wharf 1 Churchill PlaceChrysorroiatissi 11, 3032 Limassol, Cyprus.
Offered Asset Classes & ServicesFinancial services, retail banking, commercial banking, investment banking, investment managementCryptocurrencies, Precious metals, Indices, Forex, Stocks, Futures, Commodities
Execution Software & TerminalsProprietary / Web PlatformProprietary / Web Platform
Supported Client LanguagesChinese (Simplified), Chinese (Traditional), EnglishOther languages, Spanish, Italian, English, French
Warning / Exposure Count0 recorded warning(s)0 recorded warning(s)
Specialized Sub-Page Audits

Compare Barclays and Conotoxia against other regulated peers in our cross-border payment institutions, msbs, remittance corridors, insurance and fiduciary trusts slice.

Frequently Asked Questions: Barclays vs Conotoxia

Deterministic counterparty comparison answers derived from supervisory records.

Which institution has stronger regulatory oversight: Barclays or Conotoxia?

Conotoxia holds more active regulated filings (3 vs 2). Specifically, Barclays maintains 2 total recorded filing(s) (Financial Conduct Authority (UK FCA), Prudential Regulation Authority (Bank of England PRA)) with 0 warning flag(s), whereas Conotoxia maintains 3 recorded filing(s) (CYSEC, KNF, CONSOB) with 0 warning flag(s). Always confirm the specific subsidiary onboarding your account on the official regulator register.

How do the 6D quantitative compliance scores compare between Barclays and Conotoxia?

In PayClear Ledger's 6-Dimension scoring matrix (0.0–10.0 scale), Barclays records an Overall Score of 5.0 (Risk & Licensing: 5.0, Brand: 5.0, Market Influence: 5.0, User Reputation: 0.0, Execution & Software: 3.0), compared with Conotoxia at 6.1 Overall (Risk & Licensing: 5.0, Brand: 6.3, Market Influence: 5.0, User Reputation: 0.0, Execution & Software: 4.0).

How do Barclays and Conotoxia differ in trading platforms and asset classes?

Barclays lists Financial services, retail banking, commercial banking, investment banking, investment management with execution software [proprietary/web execution], while Conotoxia lists Cryptocurrencies, Precious metals, Indices, Forex, Stocks, Futures, Commodities with execution software [proprietary/web execution]. Counterparties should verify FIX/API connectivity, server routing topology, and negative balance protection per entity.

Which counterparty carries lower regulatory warning and complaint exposure: Barclays or Conotoxia?

Barclays carries a "Risk level not supplied" classification with 0 warning/exposure count(s) and 0 user comment(s), while Conotoxia carries a "Risk level not supplied" classification with 0 warning/exposure count(s) and 0 user comment(s).

Structured against supervisory register snapshots and public regulatory filings. Verify your contracting legal entity and current authorisation status directly on the issuing regulator’s official register before transacting.

Barclays vs Conotoxia (2026) — Regulation, 6D Score, Safety & Fee Comparison | PayClear Ledger